Scheimpflug imaging is effective for detecting narrow angles

Article

Data recently published in Eye has demonstrated that anterior chamber volume (ACV) measurements taken with Scheimpflug imaging is better for detecting narrow angles than spectral domain anterior segment optical coherence tomography (SD-ASOCT).

Data recently published in Eye has demonstrated that anterior chamber volume (ACV) measurements taken with Scheimpflug imaging is better for detecting narrow angles than spectral domain anterior segment optical coherence tomography (SD-ASOCT).

A team led by Dr D.S. Grewal, Department of Ophthalmology, Northwestern University of Feinberg School of Medicine, Chicago, USA, conducted a prospective, cross-sectional, observational study on 265 eyes of 265 patients. Each patient underwent sequential Schiempflug, SD-ASOCT imaging and gonioscopy. The outcome measures included area under receiver operating characteristic curve (AUC), sensitivity, specificity, and likelihood ratios (LRs). These were used to measure the performance of ACV, anterior chamber depth (ACD), angle opening distance (AOD500), and trabecular-iris space area (TISA500) in detecting narrow angles.

Of the eyes studied, 28 eyes were identified as narrow angles on gonioscopy. When detecting narrow angles ACD and ACV performed similarly to each other and significantly better than the nasal and temporal for both AOD500 and TISA500.

The findings demonstrated overall sensitivity and specificity for detecting narrow angles of ACV was 90% and 88%, respectively. The positive and negative LRs were 8.63 and 0.11, respectively. The use of Scheimpflug imaging to perform ACV measurements is more successful than AOD500 and TISA500 for the detection of narrow angles.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.